Skip to content

Study · Animal study (in vivo) · mouse · 2007

1 result

Immunopharmacology of thymosin alpha1 and cytokine synergy.

Naylor PH, Quadrini K, Garaci E, Rasi G, Hadden JW

Annals of the New York Academy of Sciences13 Jun 2007Cited by 18 (Europe PMC)

PMID17567942 (opens in a new tab)DOI10.1196/annals.1415.036 (opens in a new tab)PepBankPUB-17567942
Publisher pagePubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

1 result from studies that gave the peptide. No result from this study comes from people.

  1. 01AnimalAnimal study (in vivo)Efficacy outcome

    In Lewis lung carcinoma mice treated with IRX-2, adding Talpha1 significantly improved survival compared with IRX-2 alone.

    In plain wordsIn mice with lung cancer, adding Talpha1 to IRX-2 improved survival compared with IRX-2 alone.

    Peptide
    Thymosin alpha-1
    Outcome
    IncreaseSurvival of tumor-bearing mice
    Study

    mousen: not reported in source

    Lewis lung carcinoma tumor-bearing mice
    Comparator
    IRX-2 alone
    Outcome group
    Tumor growth · Cancer
    Studied dose
    Dose not stated

    Source sentences

    Summary
    adding Talpha1 led to significant improvement in survival of the tumor-bearing mice.
    1 context sentence
    Summary · context
    We extended those studies with the Lewis lung carcinoma mouse model using IRX-2, a natural well-defined biologic containing multiple cytokines, in combination with Talpha1 (IRX-3).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 3Current

    10 Oct 2026, 08:55 UTC

    Study results updated

  2. Version 2

    9 Oct 2026, 03:03 UTC

    Study data updated · source update from Europe PMC

  3. Version 1

    9 Oct 2026, 03:02 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.